Why is ANG Lifesciences falling/rising?

As of 26-Jun, ANG Lifesciences India Ltd is currently priced at 27.83, reflecting an increase of 0.17 or 0.61%. Despite this slight uptick, the stock has shown a significant decline over the past week, down 4.50%, and a year-to-date drop of 37.73%. The stock is trading below its moving averages across all time frames, indicating a bearish trend. However, there has been a notable increase in investor participation, with delivery volume rising by 81.92% against the 5-day average. The company has faced persistent challenges, reporting operating losses and negative results for the last 12 consecutive quarters, which has contributed to its weak long-term fundamental strength. Additionally, a high Debt to EBITDA ratio and a negative return on equity further exacerbate the stock's risk profile.
In the broader market context, ANG Lifesciences has underperformed significantly compared to the benchmark, with a one-year return of -45.75% against the Sensex's gain of 6.46%. This consistent underperformance over the last three years highlights the stock's struggles relative to the market. The high percentage of pledged promoter shares adds further downward pressure, particularly in a declining market. Overall, while there was a minor price increase today, the underlying fundamentals and historical performance suggest a challenging outlook for ANG Lifesciences, making it a risky investment compared to the broader market.